Compare TAK & KDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAK | KDP |
|---|---|---|
| Founded | 1781 | 1981 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3B | 37.4B |
| IPO Year | N/A | 1993 |
| Metric | TAK | KDP |
|---|---|---|
| Price | $16.76 | $27.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $35.06 |
| AVG Volume (30 Days) | 2.8M | ★ 9.9M |
| Earning Date | 01-29-2026 | 02-24-2026 |
| Dividend Yield | 3.12% | ★ 3.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.14 | ★ 1.16 |
| Revenue | ★ $29,846,840,032.00 | $16,174,000,000.00 |
| Revenue This Year | N/A | $8.11 |
| Revenue Next Year | $0.47 | $4.75 |
| P/E Ratio | $121.37 | ★ $23.83 |
| Revenue Growth | N/A | ★ 6.77 |
| 52 Week Low | $12.99 | $25.03 |
| 52 Week High | $16.93 | $36.12 |
| Indicator | TAK | KDP |
|---|---|---|
| Relative Strength Index (RSI) | 68.42 | 42.12 |
| Support Level | $15.78 | $27.21 |
| Resistance Level | $16.93 | $27.85 |
| Average True Range (ATR) | 0.23 | 0.54 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 85.22 | 18.43 |
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.